Aleksey N. Kislyakov

Aleksey N. Kislyakov

Auto-generated profile, based on publicly available information

Aleksey N. Kislyakov

Morozov Children’s Clinical Hospital

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EBEkaterina Bychkova
Ekaterina Bychkova
MDMarina Dorofeeva
Marina Dorofeeva
ALAleksandr Levov
Aleksandr Levov
AKAlexey Kislyakov
Alexey Kislyakov
KKKristina Karandasheva
Kristina Karandasheva
KAKirill Anoshkin
Kirill Anoshkin
Patients with tuberous sclerosis complex present with cognitive, behavioral, and psychiatric impairments, such as intellectual disabilities, autism spectrum disorders, and drug-resistant epilepsy. It has been shown that these disorders are associated with the presence of cortical tubers. Tuberous sclerosis complex results from inactivating mutations in the TSC1 or TSC2 genes, resulting in hyperactivation of the mTOR signaling pathway, which regulates cell growth, proliferation, survival, and autophagy. TSC1 and TSC2 are classified as tumor suppressor genes and function according to Knudson’s two-hit hypothesis, which requires both alleles to be damaged for tumor formation. However, a second-hit mutation is a rare event in cortical tubers. This suggests that the molecular mechanism of cortical tuber formation may be more complicated and requires further research. This review highlights the issues of molecular genetics and genotype–phenotype correlations, considers histopathological characteristics and the mechanism of morphogenesis of cortical tubers, and also presents data on the relationship between these formations and the development of neurological manifestations, as well as treatment options.

1 July 2022 in Surgical Neurology International
Verified
Journal Article
Open access
INIlya O. Nosov
Ilya O. Nosov
AKAlexei N. Kislyakov
Alexei N. Kislyakov
MLMatvey I. Livshits
Matvey I. Livshits
PLPavel V. Lobankin
Pavel V. Lobankin
GCGennady E. Chmutin
Gennady E. Chmutin
GMGerald Musa
Gerald Musa
Background: Neuroenteric cysts are rare cystic benign neoplasms of the central nervous system most often located in the spinal cord and rarely, intracranially. The nonspecific neuroimaging features make management planning potentially challenging. We present a case of a radiologically misdiagnosed neurenteric cyst with a complicated course. Case Description: A 13-year-old girl presented with a 6-month history of headache, tinnitus, and dizziness. Initial magnetic resonance images (MRIs) were indistinguishable from a pineal arachnoid cyst with aqueductal stenosis and hydrocephalus. Cyst fenestration was performed through an infratentorial supracerebellar approach. Histology revealed a neurenteric cyst. On day 10 postoperatively, she deteriorated with acute hydrocephalus and cyst enlargement. An external ventricular drain was inserted. She remained asymptomatic thereafter. At 1-year postoperative, the patient remains asymptomatic despite the MRI showing cyst enlargement and local dissemination in the form of multiple cystic lesions in the cerebellum along the operative corridor. The patient was managed conservatively considering adhesion noted intraoperatively. Conclusion: Neuroimaging features of brain cystic lesions may be nonspecific. Special attention should be awarded to posterior fossa and paramedian cystic lesions. Rarer lesions like neurenteric cysts should also be considered. When in doubt, we recommend using the following methods to prevent the free outflow of the cyst contents into the subarachnoid space: lining the cyst and operative corridor with cotton wool and puncture opening and suctioning of fluid. However, the “gold standard” remains surgical treatment with radical excision of the endodermal cyst capsule. It is necessary to preassess the possibility of total or subtotal resection.

21 May 2021 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
LOL. V. Olkhova
L. V. Olkhova
OZO. G. Zheludkova
O. G. Zheludkova
LZL. S. Zubarovskaya
L. S. Zubarovskaya
ASA. Yu. Smirnova
A. Yu. Smirnova
YDYu. V. Dinikina
Yu. V. Dinikina
ТСТ. Ю. Скворцова
Т. Ю. Скворцова
Atypical teratoid/rhabdoid tumor (AT/RT) of the central nervous system (CNS) is an aggressive malignant tumor that is mainly found in younger children and is associated with poor prognosis. Our objectives: to present the results of treatment of children with CNS AT/RT under 3 years of age and assess the impact of various prognostic factors on patient survival. The study was approved by the Independent Ethics Committee and the Scientific Council of the N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation. The study included 106 patients with CNS AT/RT aged 0–3 years who had been treated and monitored from 2008 to 2020. The median age was 16 (9; 23) months. All the patients underwent primary tumor resection with subsequent chemotherapy according to various protocols. At the time of the analysis, 47 patients (44.4%) were alive, 1 patient (0.9%) was lost to follow-up and 58 patients (54.7%) were dead, of whom 52 patients (90%) had died of disease progression and 6 (10%) – of polychemotherapy complications. One patient developed shunt-related intraabdominal metastasis within 10 months of the diagnosis. The 1-year progression-free survival (PFS) was 0.50; the 2-year PFS was 0.29; the 5-year PFS – 0.27. The median PFS was 12 months. The 1-year overall survival (OS) was 0.72; the 2-year OS was 0.53; the 5-year OS – 0.40. The median OS was 27 months. An analysis of patients with CNS AT/RT under 3 years of age showed that PFS was statistically significantly higher in: children aged 12 months; children with totally resected tumours; children who had received polychemotherapy in accordance with the ATRT-2006 protocol that included radiotherapy and regional administration of a triplet of chemotherapeutic agents. The OS in patients with CNS AT/RT aged 3 years was statistically significantly higher in: children aged 12 months; children who had been treated with radiation therapy; patients who had received cytosar/etoposide intrathecally/intraventricularly; patients who had undergone high-dose chemotherapy with subsequent autologous hematopoietic stem cell transplantation. A multivariate analysis revealed that PFS was influenced by age, tumor location, extent of resection and exposure to radiation therapy, regional chemotherapy or high-dose chemotherapy with autologous hematopoietic stem cell transplantation, while OS was affected by age and exposure to radiation therapy.

19 July 2023 in Russian Journal of Pediatric Hematology and Oncology
Verified
Journal Article
Open access
PDF file
MRM. V. Ryzhova
M. V. Ryzhova
LOL. V. Olkhova
L. V. Olkhova
LSL. V. Shishkina
L. V. Shishkina
AGAndrey Golanov
Andrey Golanov
OZO. G. Zheludkova
O. G. Zheludkova
ЮЗЮ. М. Забродская
Ю. М. Забродская
Currently, the daily routine of a molecular pathologist is DNA methylation and RNA and DNA sequencing. The authors, from the standpoint of researchers and clinicians, explain the molecular methods used not only to diagnose brain tumors, but also to search for possible targets for therapy.

29 March 2024 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
DKD.N. Kopachev
D.N. Kopachev
MRM.V. Ryzhova
M.V. Ryzhova
AKA.N. Kislyakov
A.N. Kislyakov
ESE.G. Shaikhaev
E.G. Shaikhaev
OZO.G. Zheludkova
O.G. Zheludkova
AGA.O. Gushcha
A.O. Gushcha
Background. Methylation analysis has become a powerful diagnostic tool in modern neurooncology. This technique is valuable to diagnose new brain tumor types. Objective. To describe the MRI and histological pattern of neuroepithelial tumor with PLAGL1 gene fusion. Material and methods. We present a 6-year-old patient with small right frontal intraaxial tumor causing drug resistant epilepsy. Despite indolent preoperative clinical course and MRI features suggesting glioneuronal tumor, histological evaluation revealed characteristics of high-grade glioma, ependymoma and neuroblastoma. Results. Methylation analysis of tumor DNA confirmed a new type of a recently discovered neoplasm — neuroepithelial tumor with PLAGL1 fusion (NET PLAGL1). PCR confirmed fusion of PLAGL1 and EWSR1 genes. No seizures were observed throughout the follow-up period. There was no tumor relapse a year after surgery. Conclusion. Methylation analysis in neurooncology is essential for unclear tumor morphology or divergence between histological and clinical data. In our case, this technique confirmed benign nature of tumor, and we preferred follow-up without unnecessary adjuvant treatment.

15 April 2024 in Russian Journal of Child Neurology
Verified
Journal Article
Open access
PDF file
VKV. S. Khalilov
V. S. Khalilov
AKA. N. Kislyakov
A. N. Kislyakov
AKA. A. Kholin
A. A. Kholin
UKU. A. Kukota
U. A. Kukota
NMN. A. Medvedeva
N. A. Medvedeva
ADAlexander E. Druy
Alexander E. Druy
Diffuse leptomeningeal glioneuronal tumor was introduced into the World Health Organization classification of central nervous system tumors in 2016. According to the actual World Health Organization classification of central nervous system tumors emerged in 2021, its reliable verification requires the combination of specific pathomorphological and molecular-genetic features as well as data of the neuroimaging. Typically occurring in children and adolescents these tumors are characterized by widespread diffuse leptomeningeal dissemination along the neuraxis and demonstrate a tendency to abundant contrast enhancement resulting in a specific magnetic resonance imaging appearance. Despite this, and the rather rare incidence, a number of publications have reported an increasing number of atypical cases of diffuse leptomeningeal glioneuronal tumor suggesting that the spectrum of clinical manifestations, molecular-genetic and radiological criteria of this tumor is not fully disclosed and requiring further comprehensive investigations. The article presents the experience of complex, interdisciplinary diagnosis of diffuse leptomeningeal glioneuronal tumor with atypical radiological picture in a child with focal structural epilepsy.